Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2

Overview of attention for article published in Cancer Immunology, Immunotherapy, February 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 100 Dimensions

Readers on

mendeley: 152 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

FIBP KNOCKOUT IN T CELLS AMPLIFIES ANTITUMOR ACTIVITY BY LIMITING CHOLESTEROL METABOLISM…

Application WO-2023049768-A1

World Intellectual Property Organisation (WIPO)

CHIMERIC COSTIMULATORY RECEPTORS, CHEMOKINE RECEPTORS, AND THE USE OF SAME IN CELLULAR…

Application WO-2022225981-A3

World Intellectual Property Organisation (WIPO)

TREATMENT OF CANCER PATIENTS WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION…

Application WO-2022125941-A1

World Intellectual Property Organisation (WIPO)